Investigating the effect of RTMS on tinnitus patients
Not Applicable
Completed
- Conditions
- tinnitus.TinnitusH93.1
- Registration Number
- IRCT20240319061335N1
- Lead Sponsor
- By the patient and resident (There is no cost at all)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
A woman or man with tinnitus with an average age of 30 to 65 years2) ) No simultaneous use of drug treatments3) 4) 5)
Using the Tinnitus Handicap Inventory questionnaire2
Not using other treatment methods, including surgery and medicine, in the last 6 months
Absence of other effective diseases
Sound perception without any external physical stimulus
Exclusion Criteria
Having a middle ear infection
Having a job and activity with noise pollution
Tooth and sinus infection
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie RTMS efficacy in tinnitus treatment?
How does RTMS compare to standard-of-care treatments for chronic tinnitus?
Are there specific biomarkers that predict response to RTMS in tinnitus patients?
What are the potential adverse events associated with RTMS therapy for tinnitus?
What combination therapies are being explored alongside RTMS for tinnitus management?